KWM
IBB icon

Kingsview Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Kingsview Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$729K Buy
3,833
+192
+5% +$33K 0.01% 845
2026
Q1 		$615K Buy
3,641
+406
+13% +$69.4K 0.01% 830
2025
Q4 		$546K Buy
3,235
+34
+1% +$5.52K 0.01% 814
2025
Q3 		$462K Sell
3,201
-180
-5% -$24.6K 0.01% 825
2025
Q2 		$428K Buy
3,381
+135
+4% +$16.6K 0.01% 824
2025
Q1 		$415K Sell
3,246
-28,838
-90% -$3.91M 0.01% 784
2024
Q4 		$4.24M Buy
32,084
+28,541
+806% +$4.01M 0.08% 225
2024
Q3 		$516K Buy
3,543
+438
+14% +$63.4K 0.01% 708
2024
Q2 		$426K Buy
3,105
+284
+10% +$37.9K 0.01% 736
2024
Q1 		$387K Sell
2,821
-318
-10% -$43.4K 0.01% 736
2023
Q4 		$426K Buy
3,139
+221
+8% +$27K 0.01% 671
2023
Q3 		$357K Sell
2,918
-1,167
-29% -$148K 0.01% 705
2023
Q2 		$519K Buy
4,085
+127
+3% +$16.5K 0.02% 579
2023
Q1 		$511K Buy
3,958
+443
+13% +$58K 0.02% 570
2022
Q4 		$461K Buy
3,515
+170
+5% +$22K 0.02% 530
2022
Q3 		$391K Sell
3,345
-209
-6% -$26K 0.02% 566
2022
Q2 		$418K Sell
3,554
-485
-12% -$57.6K 0.02% 575
2022
Q1 		$526K Sell
4,039
-847
-17% -$110K 0.02% 558
2021
Q4 		$746K Buy
4,886
+396
+9% +$61.3K 0.03% 481
2021
Q3 		$726K Buy
4,490
+942
+27% +$159K 0.03% 459
2021
Q2 		$586K Sell
3,548
-42
-1% -$6.47K 0.03% 519
2021
Q1 		$544K Sell
3,590
-454
-11% -$72.1K 0.03% 491
2020
Q4 		$613K Sell
4,044
-1,973
-33% -$282K 0.04% 401
2020
Q3 		$815K Sell
6,017
-7,847
-57% -$1.06M 0.07% 264
2020
Q2 		$1.9M Buy
13,864
+10,737
+343% +$1.37M 0.19% 134
2020
Q1 		$337K Buy
3,127
+317
+11% +$36.5K 0.05% 324
2019
Q4 		$339K Buy
2,810
+90
+3% +$10K 0.04% 350
2019
Q3 		$271K Sell
2,720
-494
-15% -$51.7K 0.04% 355
2019
Q2 		$351K Sell
3,214
-4,290
-57% -$456K 0.06% 300
2019
Q1 		$839K Buy
7,504
+4,214
+128% +$462K 0.13% 194
2018
Q4 		$317K Buy
3,290
+268
+9% +$28.4K 0.07% 279
2018
Q3 		$369K Sell
3,022
-150
-5% -$17.7K 0.07% 262
2018
Q2 		$348K Sell
3,172
-17
-0.5% -$1.82K 0.08% 246
2018
Q1 		$340K Sell
3,189
-1,554
-33% -$172K 0.08% 243
2017
Q4 		$506K Sell
4,743
-1,071
-18% -$114K 0.18% 168
2017
Q3 		$646K Buy
5,814
+1,932
+50% +$206K 0.28% 112
2017
Q2 		$401K Buy
3,882
+840
+28% +$82.7K 0.21% 145
2017
Q1 		$297K Buy
+3,042
New +$291K 0.18% 174

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Kingsview Wealth Management's IBB Position: Q2 2026 in Review

Kingsview Wealth Management increased its iShares Biotechnology ETF (IBB) stake by 5.3% in Q2 2026, buying an estimated $33K and bringing the position to 3,833 shares worth $729K. The position accounts for 0.01% of the portfolio, ranked #845.

Kingsview Wealth Management first reported a position in IBB in Q1 2017 and has held it in 38 quarters since. The position peaked at $4.24M in Q4 2024. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Kingsview Wealth Management held 3,833 shares of iShares Biotechnology ETF worth $729K as of Q2 2026.
  • Kingsview Wealth Management bought 192 iShares Biotechnology ETF shares in Q2 2026, an estimated $33K.
  • iShares Biotechnology ETF made up 0.01% of Kingsview Wealth Management's portfolio in Q2 2026, its #845 holding.
  • Kingsview Wealth Management first reported a position in iShares Biotechnology ETF in Q1 2017 and has held it in 38 quarters since.
  • Kingsview Wealth Management's iShares Biotechnology ETF position peaked at $4.24M in Q4 2024.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Kingsview Wealth Management's 13F filing for Q2 2026, filed 19 Aug 2026.